Research Article
Characterization of Mineral and Bone Metabolism Biomarkers in a Chinese Consanguineous Twin Family with Primary Hypertrophic Osteoarthropathy
Table 1
Basic information and biomarkers for mineral and bone metabolism of all members in the twin family.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Proband; #proband’s twin brother, ‡25(OH)D deficiency; ∆25(OH)D insufficiency. Abbreviations: Ca, calcium; P, phosphorus; PTH, parathyroid hormone; 25(OH)D, 25-hydroxyvitamin D; BGP, bone Gla-protein; β-CTX, C-terminal telopeptide of type I collagen; Uca/Ucr, urinary calcium/creatinine ratio. Reference range: Ca, 2.03–2.54 mmol/L; P, 0.87–1.45 mmol/L; PTH, 15–65 pg/ml; 25(OH)D, <50 nmol/L, deficiency; 50–75 nmol/L, insufficiency; >75 nmol/L, normal range; BGP, 11–43 ng/ml; β-CTX, before menopause, 30–573 pg/ml; postmenopause, 104–1008 pg/ml. |